| Device Classification Name |
Glucose Dehydrogenase, Glucose
|
| 510(k) Number |
K111268 |
| Device Name |
CONTOUR (R) NEXT BLOOD GLUCOSE MONITORING SYSTEM |
| Applicant |
| Bayer Healthcare |
| 430 S. Beiger St. |
|
Mishawaka,
IN
46544
|
|
| Applicant Contact |
WEIPING ZHONG |
| Correspondent |
| Bayer Healthcare |
| 430 S. Beiger St. |
|
Mishawaka,
IN
46544
|
|
| Correspondent Contact |
WEIPING ZHONG |
| Regulation Number | 862.1345 |
| Classification Product Code |
|
| Subsequent Product Codes |
|
| Date Received | 05/04/2011 |
| Decision Date | 03/06/2012 |
| Decision |
Substantially Equivalent
(SESE) |
| Regulation Medical Specialty |
Clinical Chemistry
|
| 510k Review Panel |
Clinical Chemistry
|
| Summary |
Summary
|
| FDA Review |
Decision Summary
|
| Type |
Traditional
|
| Clinical Trials |
NCT01264016
|
| Reviewed by Third Party |
No
|
| Combination Product |
No
|
Predetermined Change Control Plan Authorized |
No
|
| Recalls |
CDRH Recalls
|
|
|